Information on IMD58

Basic details

Name: Immunodeficiency 58 | Acronym: IMD58
Alt. names: RLTPR deficiency

Gene: CARMIL2 | MOI: Autosomal recessive | Mechanism of action: Loss of Function

No. of cases in DB: 1 | First reported in: 2016

Last updated on: 2023-02-28 16:41:18 by

OMIM: 618131

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

Immunodeficiency-58 is an autosomal recessive primary immunologic disorder characterized by early-onset skin lesions, including eczematous dermatitis, infectious abscesses, and warts, recurrent respiratory infections or allergies, and chronic persistent infections with candida, Molluscum contagiosum, mycobacteria, EBV, bacteria, and viruses. Some patients may have gastrointestinal involvement, including inflammatory bowel disease, EBV+ smooth muscle tumors, and esophagitis. Immunologic analysis shows defective T-cell function with decreased Treg cells and deficient CD3/CD28 costimulation responses in both CD4+ and CD8+ T cells. B-cell function may also be impaired (summary by Wang et al., 2016 and Alazami et al., 2018).

Management

Prophylactic measures, as well as early and aggressive treatment of infections may be beneficial. Individuals may be at increased risk of certain types of neoplasms, and awareness may allow prompt diagnosis and management.

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.

1 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code
102090arrow icon M 214309 4 Iran PMID:34390440 [HIES29]

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 Dermatitisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
2 Sinusitisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
3 Eosinophiliaarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
4 Mucocutaneous candidiasisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
5 Lymphocytosisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
6 Increased IgE levelsarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
7 Abnormal lymphoproliferationarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
8 Atopyarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
9 Allergyarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
10 Eosinophilic esophagitisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
11 Eczemaarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
12 Candida Onychomycosisarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
13 Asthmaarrow icon 1 (99.9%) 0 (0.0%) 0 (0.0%)
14 Decreased IgA levelsarrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)
15 Decreased IgG levelsarrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)
16 Decreased IgM levelsarrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)
17 Hypogammaglobulinemiaarrow icon 0 (0.0%) 1 (99.9%) 0 (0.0%)

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not been completed yet. It is currently ongoing.